InspireMD公司宣布,其SwitchGuard神经保护系统用于经颈动脉血管重建术(TCAR)的C-GUARDIANS III关键性研究,已完成首位患者的入组。
该研究旨在评估该创新系统在手术中的安全性与有效性,标志着InspireMD在神经血管介入领域的重要进展。SwitchGuard系统设计用于在TCAR过程中提供脑部保护,其临床研究的推进是公司产品管线发展的关键一步。
InspireMD公司宣布,其SwitchGuard神经保护系统用于经颈动脉血管重建术(TCAR)的C-GUARDIANS III关键性研究,已完成首位患者的入组。
该研究旨在评估该创新系统在手术中的安全性与有效性,标志着InspireMD在神经血管介入领域的重要进展。SwitchGuard系统设计用于在TCAR过程中提供脑部保护,其临床研究的推进是公司产品管线发展的关键一步。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.